North America Heart Failure Software Market, By Type (Knowledge Based, Non-Knowledge Based), Delivery Mode (Web-Based, On-Premises, Cloud-Based Systems), Platform (Standalone, Integrated), Supportive Devices (Tablets, Desktops, Others), Features (Heart Monitoring Activity, Tracking Periodic Tests, Review Progress, Diary Management Tool, Diagnosis and Therapy Monitoring, Others), End User ( Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), Distribution Channel (Direct Tenders, Third Party Distribution), Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2028.
Market Analysis and Insights: North America Heart Failure Software Market
The North America heart failure software market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 5.6% in the forecast period of 2021 to 2028 and is expected to reach USD 2,310.82 million by 2028. Increasing incidences of heart-related diseases across the North America region act as a driver for the heart failure software market growth.
Heart failure occurs when your heart is unable to pump enough blood to meet your body's needs. This can happen if your heart can't get enough blood to fill up. It can also happen if your heart isn't strong enough to pump blood properly. Heart failure does not imply that your heart has stopped beating. Heart failure, on the other hand, is a serious condition that necessitates medical attention. Ventricular Assist Devices (VADs) are revolutionizing the treatment of advanced heart failure patients by offering yet another possible solution to a growing problem. Mechanical Circulatory Support (MCS) includes VAD therapy (MCS). VADs are mechanical devices that help a weakened heart pump blood throughout the body by transferring blood from the left ventricle to the ascending aorta.
Heart failure is defined by the North American Society of Cardiology (ESC) as a clinical syndrome characterized by symptoms such as shortness of breath, persistent coughing or wheezing, ankle swelling, and fatigue, that may be accompanied by the following signs: jugular venous pressure, pulmonary crackles, increased heart rate, and peripheral oedema. However, these signs may not be present in the early stages and patients treated with diuretics. When apparent, they are due to a structural and/ or functional cardiac abnormality, leading to systolic and/or diastolic ventricular dysfunction, resulting in reduced cardiac output and/or elevated intra-cardiac pressures at rest or during stress.
The technological advancements in software and increased accessibility to personal healthcare systems is the major driving factor in the market. The interoperability of different systems or platforms existing in hospital and clinical can prove to be a challenge however, increasing demand for access to patient health records (PHR/ PHI) proves to be an opportunity. The insensitivity and unawareness among the population can be a restraint for the adoption of heart failure software and the challenges.
The heart failure software market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the heart failure software market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Heart Failure Software Market Scope and Market Size
The heart failure software market is segmented on the basis of the type, delivery mode, platform, supportive devices, features, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of type, North America heart failure software market is segmented into knowledge-based, and non-knowledge-based. In 2021, a knowledge-based segment is expected to dominate the market as it is widely deployed in North America due to continuous research and innovation in the field of medical sciences has overall enhanced the growth for the heart failure software.
- On the basis of delivery mode, North America heart failure software market is segmented into on-premises, cloud-based systems, and web-based. In 2021, the on premise segment is expected to dominate the market due to the common usage of on-premises software.
- On the basis of platform, North America heart failure software market is segmented into standalone and integrated. In 2021, the standalone segment is expected to dominate the market as there is a wide deployment of monitor and desktop in the hospital or clinics that drives the overall innovation for the heart failure software market.
- On the basis of supportive devices, the North America heart failure software market is segmented into desktops, tablets, and others. In 2021, the desktop segment is expected to dominate the market as desktop devices as multiple messages or images can live comfortably in such a wide space.
- On the basis of features, the North America heart failure software market is segmented into heart monitoring activity, tracking periodic tests, review progress, diagnosis and therapy monitoring, diary management tool, and others. In 2021, the heart monitoring activity segment is expected to dominate the market owing to growing cardiac cases and adoption of smart wearables by the patient to monitor their heart beat monitoring is driving the overall growth for the segment.
- On the basis of end user, North America heart failure software market is segmented into hospitals, specialty clinics, ambulatory surgical centers, and others.
- In 2021, the hospital is expected to dominate the market owing to the increasing adoption of electronic health records (EHR).
- On the basis of distribution channel, North America heart failure software market is segmented into direct tenders and third party distribution. In 2021, the direct tenders segment is expected to dominate the market as the knowledge base dominated the market due to SaaS, AI and machine learning.
Heart Failure Software Market Country Level Analysis
The heart failure software market is analyzed and market size information is provided by the country, type, delivery mode, platform, supportive devices, features, end user and distribution channel as referenced above.
The countries covered in the North America heart failure software market report are the U.S., Canada and Mexico.
The U.S. dominates the North America region due to its wide deployment and investment in the healthcare sector.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Increasing Usage Of Wearable Devices For Monitoring The Heart Rate Is Boosting the Market Growth of Heart Failure Software market.
The heart failure software market also provides you with detailed market analysis for every country's growth in particular market. Additionally, it provides the detail information regarding the market players’ strategy and their geographical presence. The data is available for historic period 2010 to 2019.
Competitive Landscape and Heart Failure Software Market Share Analysis
Heart failure software market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to heart failure software market.
The major companies which are dealing in the heart failure software are Medtronic, Abbott, Cerner Corporation., 4S Information Systems Ltd., Axis Clinical Software, Inc. and CV Medical Software among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many contracts and agreements are also initiated by the companies’ worldwide, which are also accelerating the heart failure software market.
For instance,
- In June 2021, Medtronic announced a clinical trial for the STROKE AF trial determining the Reveal LINQ Insertable Cardiac Monitor (ICM) superiority to detect abnormal heartbeats, otherwise known as atrial fibrillation (AF). Medtronic offers the most comprehensive range of innovative medical technology for the interventional and surgical treatment of cardiovascular disease and cardiac arrhythmias, developed in collaboration with the world's leading clinicians, researchers, and scientists. The company strives to provide high-quality products and services that provide clinical and economic value to healthcare consumers and providers.
- In December 2020, Abbott founded that more than 55% of cardiologists have heart failure at an increasing rate with pre-existing conditions such as obesity, high blood pressure, and diabetes. In addition, the company is sharing best practices with hospitals and clinics as they work to develop remote monitoring programs for patients with comorbidities like heart failure. The company had further provided solutions for the remote monitoring in COVID-19 that excel the revenue for the company.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA HEART FAILURE SOFTWARE MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 DBMR MARKET POSITION GRID
2.7 VENDOR SHARE ANALYSIS
2.8 VERTICAL GRID
2.9 MULTIVARIATE MODELING
2.1 TYPE TIMELINE CURVE
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 REGULATORY FRAMEWORK
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING INCIDENCE OF HEART-RELATED DISEASES ACROSS THE GLOBE
6.1.2 TECHNOLOGICAL ADVANCEMENTS IN SOFTWARE AND INCREASED ACCESSIBILITY TO PERSONAL HEALTHCARE SYSTEMS
6.1.3 GROWING NECESSITY OF CONSTANT HEALTH ASSESSMENT
6.1.4 RISING AGEING POPULATION
6.2 RESTRAINTS
6.2.1 INSENSITIVITY AND UNAWARENESS AMONG THE POPULATION
6.2.2 HIGH COST AND NON-AFFORDABILITY OF HEART FAILURE SOFTWARE
6.3 OPPORTUNITIES
6.3.1 INCREASING DEMAND FOR ACCESS TO PATIENT HEALTH RECORDS (PHR/ PHI)
6.3.2 ADVANCEMENT IN PERSONAL MEDICAL DEVICES
6.3.3 GOVERNMENT AND INTERNATIONAL INITIATIVES FOR THE MONITORING DEVICES
6.3.4 INCREASING USAGE OF WEARABLE DEVICES FOR MONITORING THE HEART RATE
6.3.5 INCREASING PENETRATION OF VIRTUAL HEALTHCARE SYSTEMS
6.4 CHALLENGE
6.4.1 INTEROPERABILITY OF DIFFERENT SYSTEMS OR PLATFORMS EXISTING IN HOSPITAL AND CLINICAL
7 IMPACT OF COVID-19 ON NORTH AMERICA HEART FAILURE SOFTWARE MARKET
7.1 ANALYSIS ON IMPACT OF COVID-19 ON NORTH AMERICA HEART FAILURE SOFTWARE MARKET
7.2 IMPACT ON PRICE
7.3 IMPACT ON DEMAND
7.4 IMPACT ON SUPPLY CHAIN
7.5 STRATEGIC DECISIONS FOR MANUFACTURER/SERVICE PROVIDER
7.5.1 HOME MONITORING:
7.5.2 FORWARD TRIAGE:
7.5.3 RISE OF VIRTUAL VISIT:
7.6 CONCLUSION
8 NORTH AMERICA HEART FAILURE SOFTWARE MARKET, BY TYPE
8.1 OVERVIEW
8.2 KNOWLEDGE BASED
8.2.1 ON-PREMISES
8.2.2 CLOUD-BASED SYSTEMS
8.2.3 WEB-BASED
8.3 NON-KNOWLEDGE BASED
8.3.1 ON-PREMISES
8.3.2 CLOUD-BASED SYSTEMS
8.3.3 WEB-BASED
9 NORTH AMERICA HEART FAILURE SOFTWARE MARKET, BY DELIVERY MODE
9.1 OVERVIEW
9.2 ON-PREMISES
9.2.1 DESKTOPS
9.2.2 TABLETS
9.2.3 OTHERS
9.3 CLOUD-BASED SYSTEMS
9.3.1 DESKTOPS
9.3.2 TABLETS
9.3.3 OTHERS
9.4 WEB-BASED
9.4.1 DESKTOPS
9.4.2 TABLETS
9.4.3 OTHERS
10 NORTH AMERICA HEART FAILURE SOFTWARE MARKET, BY PLATFORM
10.1 OVERVIEW
10.2 STANDALONE
10.2.1 ON-PREMISES
10.2.2 CLOUD-BASED SYSTEMS
10.2.3 WEB-BASED
10.3 INTEGRATED
10.3.1 ON-PREMISES
10.3.2 CLOUD-BASED SYSTEMS
10.3.3 WEB-BASED
11 NORTH AMERICA HEART FAILURE SOFTWARE MARKET, BY SUPPORTIVE DEVICES
11.1 OVERVIEW
11.2 DESKTOPS
11.3 TABLETS
11.4 OTHERS
12 NORTH AMERICA HEART FAILURE SOFTWARE MARKET, BY FEATURES
12.1 OVERVIEW
12.2 HEART MONITORING ACTIVITY
12.3 TRACKING PERIODIC TESTS
12.4 REVIEW PROGRESS
12.5 DIAGNOSIS AND THERAPY MONITORING
12.6 DIARY MANAGEMENT TOOL
12.6.1 SCHEDULING
12.6.2 REMINDER FUNCTIONS
12.7 OTHERS
13 NORTH AMERICA HEART FAILURE SOFTWARE MARKET, BY END USER
13.1 OVERVIEW
13.2 HOSPITALS
13.2.1 LONG -TERM CARE HOSPITALS
13.2.2 ACUTE CARE HOSPITALS
13.3 AMBULATORY SURGICAL CENTERS
13.4 SPECIALTY CLINICS
13.5 OTHERS
14 NORTH AMERICA HEART FAILURE SOFTWARE MARKET, BY DISTRIBUTION CHANNEL
14.1 OVERVIEW
14.2 DIRECT TENDERS
14.3 THIRD PARTY DISTRIBUTION
15 NORTH AMERICA HEART FAILURE SOFTWARE MARKET, BY GEOGRAPHY
15.1 NORTH AMERICA
15.1.1 U.S.
15.1.2 CANADA
15.1.3 MEXICO
16 NORTH AMERICA HEART FAILURE SOFTWARE MARKET: COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
17 SWOT
18 COMPANY PROFILE
18.1 MEDTRONIC
18.1.1 COMPANY SNAPSHOT
18.1.2 REVENUE ANALYSIS
18.1.3 COMPANY SHRAE ANALYSIS
18.1.4 PRODUCT PORTFOLIO
18.1.5 RECENT DEVELOPMENTS
18.2 ABBOTT
18.2.1 COMPANY SNAPSHOT
18.2.2 REVENUE ANALYSIS
18.2.3 COMPANY SHARE ANALYSIS
18.2.4 PRODUCT PORTFOLIO
18.2.5 RECENT DEVELOPMENTS
18.3 CERNER CORPORATION
18.3.1 COMPANY SNAPSHOT
18.3.2 REVENUE ANALYSIS
18.3.3 COMPANY SHARE ANALYSIS
18.3.4 APP PORTFOLIO
18.3.5 RECENT DEVELOPMENTS
18.4 AXIS CLINICAL SOFTWARE, INC.
18.4.1 COMPANY SNAPSHOT
18.4.2 PRODUCT/ SERVICE PORTFOLIO
18.4.3 RECENT DEVELOPMENTS
18.5 CV MEDICAL SOFTWARE
18.5.1 COMPANY SNAPSHOT
18.5.2 PRODUCT PORTFOLIO
18.5.3 RECENT DEVELOPMENT
18.6 4S INFORMATION SYSTEMS LTD.
18.6.1 COMPANY SNAPSHOT
18.6.2 PRODUCT PORTFOLIO
18.6.3 RECENT DEVELOPMENT
19 QUESTIONNAIRE
20 RELATED REPORTS
List of Table
LIST OF TABLES
TABLE 1 TOTAL COST OF HEART FAILURE COMPONENTS
TABLE 2 NORTH AMERICA HEART FAILURE SOFTWARE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 3 NORTH AMERICA KNOWLEDGE BASED IN HEART FAILURE SOFTWARE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 4 NORTH AMERICA KNOWLEDGE BASED IN HEART FAILURE SOFTWARE MARKET, BY DELIVERY MODE,2019-2028 (USD MILLION)
TABLE 5 NORTH AMERICA NON-KNOWLEDGE BASED IN HEART FAILURE SOFTWARE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 6 NORTH AMERICA NON-KNOWLEDGE BASED IN HEART FAILURE SOFTWARE MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)
TABLE 7 NORTH AMERICA HEART FAILURE SOFTWARE MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)
TABLE 8 NORTH AMERICA ON-PREMISES IN HEART FAILURE SOFTWARE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 NORTH AMERICA ON-PREMISES IN HEART FAILURE SOFTWARE MARKET, BY SUPPORTIVE DEVICES 2019-2028 (USD MILLION)
TABLE 10 NORTH AMERICA CLOUD-BASED SYSTEMS IN HEART FAILURE SOFTWARE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 NORTH AMERICA CLOUD-BASED SYSTEMS IN HEART FAILURE SOFTWARE MARKET, BY SUPPORTIVE, DEVICES 2019-2028 (USD MILLION)
TABLE 12 NORTH AMERICA WEB-BASED IN HEART FAILURE SOFTWARE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 NORTH AMERICA WEB-BASED IN HEART FAILURE SOFTWARE MARKET, BY SUPPORTIVE DEVICES, 2019-2028 (USD MILLION)
TABLE 14 NORTH AMERICA HEART FAILURE SOFTWARE MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 15 NORTH AMERICA STANDALONE IN HEART FAILURE SOFTWARE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 NORTH AMERICA STANDALONE IN HEART FAILURE SOFTWARE MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)
TABLE 17 NORTH AMERICA INTEGRATED IN HEART FAILURE SOFTWARE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 NORTH AMERICA INTEGRATED IN HEART FAILURE SOFTWARE MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)
TABLE 19 NORTH AMERICA HEART FAILURE SOFTWARE MARKET, BY SUPPORTIVE DEVICES, 2019-2028 (USD MILLION)
TABLE 20 NORTH AMERICA DESKTOP IN HEART FAILURE SOFTWARE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 NORTH AMERICA TABLETS IN HEART FAILURE SOFTWARE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 NORTH AMERICA OTHERS IN HEART FAILURE SOFTWARE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 NORTH AMERICA HEART FAILURE SOFTWARE MARKET, BY FEATURES, 2019-2028 (USD MILLION)
TABLE 24 NORTH AMERICA HEART MONITORING ACTIVITY IN HEART FAILURE SOFTWARE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 NORTH AMERICA TRACKING PERIOD TEST IN HEART FAILURE SOFTWARE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 NORTH AMERICA REVIEW PROGRESS IN HEART FAILURE SOFTWARE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 NORTH AMERICA DIAGNOSIS AND THERAPY IN HEART FAILURE SOFTWARE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 NORTH AMERICA DAIRY MANAGEMENT TOOL IN HEART FAILURE SOFTWARE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 NORTH AMERICA DIARY MANAGEMENT TOOL IN HEART FAILURE SOFTWARE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 30 NORTH AMERICA OTHERS IN HEART FAILURE SOFTWARE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 NORTH AMERICA HEART FAILURE SOFTWARE MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 32 NORTH AMERICA HOSPITALS IN HEART FAILURE SOFTWARE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 33 NORTH AMERICA HOSPITALS IN HEART FAILURE SOFTWARE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 34 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN HEART FAILURE SOFTWARE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 35 NORTH AMERICA SPECIALTY CLINICS IN HEART FAILURE SOFTWARE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 36 NORTH AMERICA OTHERS IN HEART FAILURE SOFTWARE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 37 NORTH AMERICA HEART FAILURE SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 38 NORTH AMERICA DIRECT TENDERS IN HEART FAILURE SOFTWARE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 39 NORTH AMERICA THIRD PARTY DISTRIBUTION IN HEART FAILURE SOFTWARE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 40 NORTH AMERICA HEART FAILURE SOFTWARE MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 41 NORTH AMERICA HEART FAILURE SOFTWARE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 42 NORTH AMERICA KNOWLEDGE BASED IN HEART FAILURE SOFTWARE MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)
TABLE 43 NORTH AMERICA NON-KNOWLEDGE BASED IN HEART FAILURE SOFTWARE MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)
TABLE 44 NORTH AMERICA HEART FAILURE SOFTWARE MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)
TABLE 45 NORTH AMERICA ON-PREMISES IN HEART FAILURE SOFTWARE MARKET, BY SUPPORTIVE DEVICES, 2019-2028 (USD MILLION)
TABLE 46 NORTH AMERICA CLOUD-BASED SYSTEMS IN HEART FAILURE SOFTWARE MARKET, BY SUPPORTIVE DEVICES, 2019-2028 (USD MILLION)
TABLE 47 NORTH AMERICA WEB-BASED IN HEART FAILURE SOFTWARE MARKET, BY SUPPORTIVE DEVICES, 2019-2028 (USD MILLION)
TABLE 48 NORTH AMERICA HEART FAILURE SOFTWARE MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 49 NORTH AMERICA STANDALONE IN HEART FAILURE SOFTWARE MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)
TABLE 50 NORTH AMERICA INTEGRATED IN HEART FAILURE SOFTWARE MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)
TABLE 51 NORTH AMERICA HEART FAILURE SOFTWARE MARKET, BY SUPPORTIVE DEVICES, 2019-2028 (USD MILLION)
TABLE 52 NORTH AMERICA HEART FAILURE SOFTWARE MARKET, BY FEATURES, 2019-2028 (USD MILLION)
TABLE 53 NORTH AMERICA DIARY MANAGEMENT TOOL IN HEART FAILURE SOFTWARE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 54 NORTH AMERICA HEART FAILURE SOFTWARE MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 55 NORTH AMERICA HOSPITALS IN HEART FAILURE SOFTWARE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 56 NORTH AMERICA HEART FAILURE SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 57 U.S. HEART FAILURE SOFTWARE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 58 U.S. KNOWLEDGE BASED IN HEART FAILURE SOFTWARE MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)
TABLE 59 U.S. NON-KNOWLEDGE BASED IN HEART FAILURE SOFTWARE MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)
TABLE 60 U.S. HEART FAILURE SOFTWARE MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)
TABLE 61 U.S. ON-PREMISES IN HEART FAILURE SOFTWARE MARKET, BY SUPPORTIVE DEVICES, 2019-2028 (USD MILLION)
TABLE 62 U.S. CLOUD-BASED SYSTEMS IN HEART FAILURE SOFTWARE MARKET, BY SUPPORTIVE DEVICES, 2019-2028 (USD MILLION)
TABLE 63 U.S. WEB-BASED IN HEART FAILURE SOFTWARE MARKET, BY SUPPORTIVE DEVICES, 2019-2028 (USD MILLION)
TABLE 64 U.S. HEART FAILURE SOFTWARE MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 65 U.S. STANDALONE IN HEART FAILURE SOFTWARE MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)
TABLE 66 U.S. INTEGRATED IN HEART FAILURE SOFTWARE MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)
TABLE 67 U.S. HEART FAILURE SOFTWARE MARKET, BY SUPPORTIVE DEVICES, 2019-2028 (USD MILLION)
TABLE 68 U.S. HEART FAILURE SOFTWARE MARKET, BY FEATURES, 2019-2028 (USD MILLION)
TABLE 69 U.S. DIARY MANAGEMENT TOOL IN HEART FAILURE SOFTWARE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 70 U.S. HEART FAILURE SOFTWARE MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 71 U.S. HOSPITALS IN HEART FAILURE SOFTWARE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 72 U.S. HEART FAILURE SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 73 CANADA HEART FAILURE SOFTWARE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 74 CANADA KNOWLEDGE BASED IN HEART FAILURE SOFTWARE MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)
TABLE 75 CANADA NON-KNOWLEDGE BASED IN HEART FAILURE SOFTWARE MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)
TABLE 76 CANADA HEART FAILURE SOFTWARE MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)
TABLE 77 CANADA ON-PREMISES IN HEART FAILURE SOFTWARE MARKET, BY SUPPORTIVE DEVICES, 2019-2028 (USD MILLION)
TABLE 78 CANADA CLOUD-BASED SYSTEMS IN HEART FAILURE SOFTWARE MARKET, BY SUPPORTIVE DEVICES, 2019-2028 (USD MILLION)
TABLE 79 CANADA WEB-BASED IN HEART FAILURE SOFTWARE MARKET, BY SUPPORTIVE DEVICES, 2019-2028 (USD MILLION)
TABLE 80 CANADA HEART FAILURE SOFTWARE MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 81 CANADA STANDALONE IN HEART FAILURE SOFTWARE MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)
TABLE 82 CANADA INTEGRATED IN HEART FAILURE SOFTWARE MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)
TABLE 83 CANADA HEART FAILURE SOFTWARE MARKET, BY SUPPORTIVE DEVICES, 2019-2028 (USD MILLION)
TABLE 84 CANADA HEART FAILURE SOFTWARE MARKET, BY FEATURES, 2019-2028 (USD MILLION)
TABLE 85 CANADA DIARY MANAGEMENT TOOL IN HEART FAILURE SOFTWARE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 86 CANADA HEART FAILURE SOFTWARE MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 87 CANADA HOSPITALS IN HEART FAILURE SOFTWARE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 88 CANADA HEART FAILURE SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 89 MEXICO HEART FAILURE SOFTWARE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 90 MEXICO KNOWLEDGE BASED IN HEART FAILURE SOFTWARE MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)
TABLE 91 MEXICO NON-KNOWLEDGE BASED IN HEART FAILURE SOFTWARE MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)
TABLE 92 MEXICO HEART FAILURE SOFTWARE MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)
TABLE 93 MEXICO ON-PREMISES IN HEART FAILURE SOFTWARE MARKET, BY SUPPORTIVE DEVICES, 2019-2028 (USD MILLION)
TABLE 94 MEXICO CLOUD-BASED SYSTEMS IN HEART FAILURE SOFTWARE MARKET, BY SUPPORTIVE DEVICES, 2019-2028 (USD MILLION)
TABLE 95 MEXICO WEB-BASED IN HEART FAILURE SOFTWARE MARKET, BY SUPPORTIVE DEVICES, 2019-2028 (USD MILLION)
TABLE 96 MEXICO HEART FAILURE SOFTWARE MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 97 MEXICO STANDALONE IN HEART FAILURE SOFTWARE MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)
TABLE 98 MEXICO INTEGRATED IN HEART FAILURE SOFTWARE MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)
TABLE 99 MEXICO HEART FAILURE SOFTWARE MARKET, BY SUPPORTIVE DEVICES, 2019-2028 (USD MILLION)
TABLE 100 MEXICO HEART FAILURE SOFTWARE MARKET, BY FEATURES, 2019-2028 (USD MILLION)
TABLE 101 MEXICO DIARY MANAGEMENT TOOL IN HEART FAILURE SOFTWARE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 102 MEXICO HEART FAILURE SOFTWARE MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 103 MEXICO HOSPITALS IN HEART FAILURE SOFTWARE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 104 MEXICO HEART FAILURE SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
List of Figure
LIST OF FIGURES
FIGURE 1 NORTH AMERICA HEART FAILURE SOFTWARE MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA HEART FAILURE SOFTWARE MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA HEART FAILURE SOFTWARE MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA HEART FAILURE SOFTWARE MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA HEART FAILURE SOFTWARE MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA HEART FAILURE SOFTWARE MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA HEART FAILURE SOFTWARE MARKET: DBMR MARKET POSITION GRID
FIGURE 8 NORTH AMERICA HEART FAILURE SOFTWARE MARKET: VENDOR SHARE ANALYSIS
FIGURE 9 NORTH AMERICA HEART FAILURE SOFTWARE MARKET: SEGMENTATION
FIGURE 10 TECHNOLOGICAL ADVANCEMENTS IN SOFTWARE AND INCREASED ACCESSIBILITY TO PERSONAL HEALTHCARE SYSTEMSIS EXPECTED TO DRIVE NORTH AMERICA HEART FAILURE SOFTWARE MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 11 COPPER WIRE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF NORTH AMERICA HEART FAILURE SOFTWARE MARKET IN 2021 & 2028
FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF NORTH AMERICA HEART FAILURE SOFTWARE MARKET
FIGURE 13 DEATH RATES FROM HEART AND CIRCULATORY DISEASES (CVD), UK, 1969 TO 2018
FIGURE 14 DIGITAL HEALTH APP SHARE, 2014
FIGURE 15 PERSONAL HEALTH RECORD (PHR) AND ELECTRONIC HEALTH RECORD (EHR) RELATIONSHIPS IOT: INTERNET OF THINGS
FIGURE 16 COMMON STAGES OF GOVERNMENT REGULATIONS
FIGURE 17 INTERPLAY BETWEEN COVID-19, HEART FAILURE (HF) AND REMOTE TECHNOLOGIES.
FIGURE 18 ADVANCEMENT IN THE RISE OF VIRTUAL VISITS.
FIGURE 19 NORTH AMERICA HEART FAILURE SOFTWARE MARKET: BY TYPE, 2020
FIGURE 20 NORTH AMERICA HEART FAILURE SOFTWARE MARKET: BY DELIVERY MODE, 2020
FIGURE 21 NORTH AMERICA HEART FAILURE SOFTWARE MARKET: BY PLATFORM, 2020
FIGURE 22 NORTH AMERICA HEART FAILURE SOFTWARE MARKET: BY SUPPORTIVE DEVICES, 2020
FIGURE 23 NORTH AMERICA HEART FAILURE SOFTWARE MARKET: BY FEATURES, 2020
FIGURE 24 NORTH AMERICA HEART FAILURE SOFTWARE MARKET: BY END USER, 2020
FIGURE 25 NORTH AMERICA HEART FAILURE SOFTWARE MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 26 NORTH AMERICA HEART FAILURE SOFTWARE MARKET: SNAPSHOT (2020)
FIGURE 27 NORTH AMERICA HEART FAILURE SOFTWARE MARKET: BY COUNTRY (2020)
FIGURE 28 NORTH AMERICA HEART FAILURE SOFTWARE MARKET: BY COUNTRY (2021 & 2028)
FIGURE 29 NORTH AMERICA HEART FAILURE SOFTWARE MARKET: BY COUNTRY (2020 & 2028)
FIGURE 30 NORTH AMERICA HEART FAILURE SOFTWARE MARKET: BY TYPE (2021-2028)
FIGURE 31 NORTH AMERICA HEART FAILURE SOFTWARE MARKET: COMPANY SHARE 2020(%)
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
